Beyond the Counter: The Public Health Risks of Symptom-Based Treatment
People often turn to painkillers to relieve headaches, antibiotics for a sore throat, or cough syrups to alleviate ...
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human ...
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...
Channel NewsAsia Singapore12 小时
Codeine cough syrup made up majority of illegal health products seized by HSA in 2024
SINGAPORE: Codeine cough syrup made up the majority of illegal health products seized by authorities in 2024, the Health Sciences Authority (HSA) said on Monday (Feb 3). Authoriti ...
Exxel Pharma to Participate in a "New to Virtual Investor" Segment
AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated ...
The Herald Journal4 天
Trevi Therapeutics to Participate in Upcoming February Investor Conferences
NEW HAVEN, Conn., Jan. 30, 2025 /PRNewswire/ -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the ...